The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension

Clinical trial NCT01062763 · COMPLETED

Trial details

NCT number: NCT01062763
Sponsor: Ib Abildgaard Jacobsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arterial Hypertension Hypertension, Resistant to Conventional Therapy Diabetes Mellitus

Start date: 2010-03-01
Primary completion: 2012-03-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.